MEDTRONIC TRANSCATHETER VALVE
Report
- Report Number
- 2025587-2021-01865
- Event Type
- Injury
- Date Received
- June 12, 2021
- Date of Event
- September 4, 2020
- Report Date
- June 11, 2021
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
CITATION: ELZENEINI M., ET AL. PREDICTORS OF VENTRICULAR PACING BURDEN AFTER PERMANENT PACEMAKER IMPLANTATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT. CLIN CARDIOL, 2020 NOV; 43(11): 1334¿1342. PUBLISHED ONLINE 2020 SEP 4. PMID: 32886389. DOI: 10.1002/CLC.23447. EARLIEST DATE OF PUBLISH USED FOR DATE OF EVENT [AND DATE OF DEATH]. [MEDTRONIC PRODUCTS REFERENCED: COREVALVE, EVOLUT R, EVOLUT PRO (PMA# P130021, PRODUCT CODE: NPT). EARLIEST APPROVED PRODUCT USED FOR PRODUCT CODE AND PMA#.] NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING THE PREDICTORS OF VENTRICULAR PACING BURDEN NEEDED AFTER PERMANENT PACEMAKER IMPLANTATION PERFORMED POST-TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR). ALL DATA WERE RETROSPECTIVELY COLLECTED FROM A SINGLE CENTER BETWEEN SEPTEMBER 2013 AND JULY 2019. THE STUDY POPULATION INCLUDED 30 PATIENTS (PREDOMINANTLY MALE, MEAN AGE 76 YEARS), 6 OF WHICH WERE IMPLANTED WITH MEDTRONIC COREVALVE, EVOLUT R OR EVOLUT PRO BIOPROSTHETIC VALVES. (UNIQUE DEVICE IDENTIFIER NUMBERS NOT PROVIDED). AMONG ALL PATIENTS, FOUR DEATHS OCCURRED DURING FOLLOW-UP. NO FURTHER INFORMATION WAS PROVIDED. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT WAS NOT DIRECTLY ASSOCIATED WITH THE DEATHS. AMONG ALL PATIENTS, ADVERSE EVENTS INCLUDED: NEW-ONSET LEFT BUNDLE BRANCH BLOCK (LBBB), HIGH-DEGREE ATRIO-VENTRICULAR BLOCK (AVB) AND SYMPTOMATIC BRADYCARDIA, ALL REQUIRING PERMANENT PACEMAKER IMPLANTATION. BASED ON THE AVAILABLE INFORMATION MEDTRONIC PRODUCT MAY HAVE BEEN ASSOCIATED WITH THE ADVERSE EVENTS. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 885198 | MEDTRONIC TRANSCATHETER VALVE | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV | NPT | MEDTRONIC HEART VALVES DIVISION | MDT-TRANS VALVE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Hospitalization| L| R |